Dr. Anthony Tolcher Joins the Scientific Advisory Board of NBE-Therapeutics
Basel, Switzerland, November 15, 2018 / B3C newswire / -- NBE Therapeutics AG, a biopharmaceutical company developing next-generation immune-stimulatory antibody-drug conjugates (iADCs™) for improved cancer therapy, today announces the appointment of Dr. …